Oxidative stress in blood platelets from schizophrenic patients

Platelets

Volumn 16, Issue 7, 2005, Pages 386-391

  Dietrich Muszalska, A ^a   Olas, B ^b   Rabe Jablonska, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Blood platelet; Oxidative stress; Reactive oxygen species (ROS); Schizophrenia; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; ENZYME; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THROMBIN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL STIMULATION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SCHIZOPHRENIA; THROMBOCYTE;

ADOLESCENT; ADULT; BLOOD PLATELETS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SCHIZOPHRENIA; STATISTICS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 27644584486     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100500128872     Document Type: Article

References (39)

1. Yao JK, Leonard S, Reddy R. Membrane phospholipids abnormalities in portmorten brains from schizophrenic patients. Schizophr Res 2000;42:7-17.
2. Horrobin DF, Manku MS, Hillman H, Iain A, Glen M. Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry 1991;30:795-805.
3. Horrobin DF. Schizophrenia as a membrane lipid disorder which is expressed throughout the body. Prostaglandins Leukotr Esent Fatty Acids 1996;55:3-7.
4. van Kammen DP, Yao JK, Goetz K. Polyunsaturated fatty acids, prostaglandins, and schizophrenia. Ann NY Acad Sci 1989;559:411-23.
5. Abdalla DSP, Manteiro HP, Olivera JAC, Bechara EJ. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin Chem 1986;32:805-807.
6. Reddy R, Sahebarao MP, Mukherjee S, Murthy JN. Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biol Psychiatry 1991;30:409-412.
7. Yao JK, Reddy RD, Kammen DP. Oxidative damage and schizophrenia. CNS Drugs 2001;15:287-310.
8. Plein H, Berk M. The platelet as a peripheral marker in psychiatric illness. Hum Psychopharmacol Clin Exp 2001;16:229-236.
9. Berk M, Plein H, Czismadia T. Super-sensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia. Int Clin Psychopharmaced 1999;14:119-122.
10. Berk M, Plein H, Belsham B. The specificy of platelet glutamate receptor supersensitivity in psychotic disorders. Life Sci 2000;66:2427-2432.
11. Reed GL, Fitzgerald ML, Polgar J. Molecular mechanisms of platelet exocytosis: Insights into the 'secrete' life of thrombocytes. Blood 2000;96:3334-3342.
12. Rendu F, Brohard-Bohn B. The platelet release reaction: Granules, constituents, secretion and functions. Platelets 2001;12:261-273.
13. Magos T. Monoaminergic influence on the visual evoked potentials (VEP). Rec Adv Hum Neurophysiol 1998;1:455-465.
14. Magos T. Correlation between platelet monoamine oxidase activity and the strength of a visual illusion. Vision Res 2001;42:2031-2035.
15. Walkowiak B, Michalak E, Koziołkiewicz W, Cierniewski CS. Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Throm Res 1989;56:763-766.
16. Wachowicz B. Adenine nucleotides in thrombocytes of birds. Cell Biochem Function 1984;2:167-170.
17. Król W, Czuba Z, Scheller S, Gabryś J, Grabiec J, Sham J. Antioxidant property of ethanolic extract of propolis (EEP) as evaluated by inhibiting the chemiluminescence oxidation of luminol. Biochem Int 1990;21:593-597.
18. Reddy RD, Yao JK. Membrane protective strategies in schizophrenia: conceptual and treatment issues. In: Peet M, Glen I, Horrobin DF, editors. Phospholipid spectrum disorder in psychiatry. Lancashire UK: Marius Press; 1999. pp 75-88.
19. Sinet PM, Garber P, Jerome H. Inactivation of human CuZn superoxide dismutase during exposure to superoxide radical and hydrogen peroxide. Bull Eur Physiopathol Respir 1981;17:91-99.
20. Khan NS, Das I. Oxidative stress and superoxide dismutase in schizophrenia. Biochem Soc Trans 1997;25:418S.
21. Mahadik SP, Mukherjee S, Scheffer R, Correnti EE, Mahadik JS. Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biol Psychiatry 1998;43:674-679.
22. Odagaki Y, Koyama T. Epinephrine- and thrombin-stimulated high-affinity GTPase activity in platelet membranes from patients with psychiatric disorders. Psychiatry Res 2002;112:111-119.
23. 2A binding in depression. J Affect Dis 2002;71:249-258.
24. Gibson GE, Huang HM. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Frontiers Biosci 2002;7:1007-1015.
25. Forde RC, Fitzgerald DJ. Reactive oxygen species and platelet activation in reperfusion injury. Circulation 1997;95:787-789.
26. Del Principe D, Menichelli A, De Matteis W, Di Corpo ML, Di Giulio S, Finazzi-Agro AF. Hydrogen peroxide has a role in the aggregation of human platelets. FEBS Lett 1985;1:142-149.
27. Del Principe D, Menichelli A, De Matteis W, Di Giulio S, Giordani M, Savini I, Finazzi Agro AF. Hydrogen peroxide is an intermediate in the platelet activation cascade triggered by collagen, but not by thrombin. Thromb Res 1991;62:365-371.
28. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 1998;91:484-490.
29. Jahn B, Hansch GM. Oxygen radical generation in human platelets: depence of 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Appl Immunol 1990;93:73-79.
30. Olas B, Wachowicz B. Modulation of cisplatin toxicity in blood platelets by glutathione depletion. Anti-Cancer Drugs 1998;9:473-478.
31. Wachowicz B, Olas B, Żbikowska HM, Buczyński A. Generation of reactive oxygen species in blood platelets. Platelets 2002;13:175-182.
32. Iuliano L, Pedersen JZ, Pratico D, Rotilio G, Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur J Biochem 1994;15:695-704.
33. Iuliano L, Colavita AR, Leo R, Pratico D, Violi F. Oxygen free radicals and platelet activation. Free Radic Biol Med 1997;22:999-1006.
34. Miller DM, Grover TA, Nayini N, Aust SD. Xanthine-oxidase- and iron-dependent lipid peroxidation. Arch Biochem Biophys 1993;301:1-7.
35. Yao JK, Reddy R, McElhinny LG, van Elhinny K. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophr Res 1998;32:1-8.
36. Dietrich-Muszalska A, Olas B, Wachowicz B. Isoprostanes, a novel marker of oxidative stress in schizophrenia. J Neurochem 2003;2(Suppl):30.
37. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: Physiology, pharmacology and clinical implications. Trends Pharmacol Sci 2002;23:1-4.
38. Greco A, Minghetti L, Levi G. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases. Neurochem Res 2000;25:1357-1364.
39. Souviget C, Cracowski JL, Stanke-Labesque F, Bessard G. Are isoprostanes a clinical marker for antioxidant drug investigation. Fundam Clin Pharmacol 2000;14:1-10.